Ahmed Kaseb

Associate Professor

  • 2540 Citations
  • 28 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ahmed Kaseb is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Liver Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot Study

Fuentes, D. T. A., Ahmed, K., Lin, J. S., Ali, R. A. H., Kaseb, A., Hassan, M. M., Szklaruk, J., Morshid, A., Hazle, J. D., Qayyum, A. & Elsayes, K. M., May 1 2019, In : Journal of computer assisted tomography. 43, 3, p. 499-506 8 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Health Insurance Portability and Accountability Act
Research Ethics Committees

Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?

Okuno, M., Newhook, T. E., Joechle, K., Kawaguchi, Y., De Bellis, M., Tzeng, C. W. D., Chun, Y. S., Aloia, T. A., Shindoh, J., Kaseb, A. O. & Vauthey, J. N., Jan 1 2019, (Accepted/In press) In : HPB.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Blood Vessels
Liver Cell Adenoma

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma

George, B., George, S. K., Shi, W., Haque, A., Shi, P., Eskandari, G., Axelson, M., Larsson, O., Kaseb, A. O. & Amin, H. M., Jan 1 2019, In : Journal of Hematology and Oncology. 12, 1, 80.

Research output: Contribution to journalArticle

Open Access
T-Cell Lymphoma
IGF Type 1 Receptor
Protein-Tyrosine Kinases
9 Citations (Scopus)

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial

Shroff, R., Javle, M., Xiao, L., Kaseb, A., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., Ahn, D. H., Bekaii-Saab, T. S. & Borad, M. J., Jun 1 2019, In : JAMA Oncology. 5, 6, p. 824-830 7 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Clinical Trials

Hepatic Arterial Bland Embolization Increases Th17 Cell Infiltration in a Syngeneic Rat Model of Hepatocellular Carcinoma

Avritscher, R., Jo, N. H., Polak, U., Cortes, A. C., Nishiofuku, H., Odisio, B. C., Takaki, H., Tam, A. L., Melancon, M. P., Yevich, S., Qayyum, A., Kaseb, A., Kichikawa, K., Gupta, S., Goldberg, S. N. & Chang, S. H., Jan 1 2019, (Accepted/In press) In : Cardiovascular and Interventional Radiology.

Research output: Contribution to journalArticle

Th17 Cells
Hepatocellular Carcinoma
Cell Movement